Double-blind randomized placebo-controlled study of bixa orellana in patients with lower urinary tract symptoms associated to benign prostatic hyperplasia
Author:
Affiliation:
1. Peruvian University Cayetano Heredia; National Hospital Cayetano Heredia; Peruvian University Cayetano Heredia, Peru
Publisher
FapUNIFESP (SciELO)
Subject
Urology
Link
http://www.scielo.br/pdf/ibju/v33n4/v33n4a06.pdf
Reference30 articles.
1. Enfermedades de la Próstata;Lawson RK,1994
2. Benign Prostatic Hyperplasia;Kirby RS,1997
3. The Hytrin Community Assessment Trial study: a one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia. HYCAT Investigator Group;Roehrborn CG;Urology,1996
4. Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT study). PROscar Safety Plus Efficacy Canadian Two year Study;Nickel JC;CMAJ,1996
5. Urologe A;Dreikorn K,1990
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Evaluation of Anticolitis and Antioxidant Properties of Bixa orellana (Bixaceae) Leaf Hydroethanolic Extract on Acetic Acid-Induced Ulcerative Colitis in Rats;Current Therapeutic Research;2022
2. Bixa orellana L. by-products’ fractions from an industrial process: antiproliferative activity on tumor cells and chemical profile;Natural Product Research;2020-10-04
3. Detection and Validation of Native Plants Traditionally Used as Medicine in Guatemala;Current Traditional Medicine;2019-06-03
4. Histomorphological changes in induced benign prostatic hyperplasia with exogenous testosterone and estradiol in adult male rats treated with aqueous ethanol extract of Secamone afzelii;Egyptian Journal of Basic and Applied Sciences;2017-03
5. A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men;Pharmaceutical Biology;2017-01-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3